Archives
FDA Approves Controversial Cholesterol-Fighting Drug Despite Criticism From Cardiologists
The FDA approved the cholesterol-fighting drug Liptruzet Friday, despite criticism from cardiologists that studies have not shown the drug to be effective in lowering patients' chances of developing heart disease.
Latest Research Articles
Drug-resistant Gonorrhea Strain 'Worse Than AIDS,' Could Bring Quick Death, Doctor Says [VIDEO]
Animal Brains A Favorite Among Early Humans: A Study
Alaska's Cleveland Volcano Erupting Since Saturday, Aviation Warnings Raised To Orange
NJ Gov. Chris Christie Kills Spider, PETA Responds [VIDEO]
Abused Women Less Likely To Be Emotionally Connected With Their Children
Study Reveals How Clouds Keep the Earth Cool
Oral Drops Just as Effective as Shots for Asthma, Allergies
Parents Sucking on the Pacifier might Lower Allergies, Asthma Risk in Children
Hawaii to be Hit by More Tropical Cyclones in the Future: Study
Researchers Treat Epilepsy in Mice
California Wildfire 30% Contained, Changes In Weather Aid The Fight
Dark Matter And Bubbles: Scientists Take A New Approach At Solving An Old Mystery
MOST POPULAR
-
Texas Teen Died After Helping Her Family Escape From Car That Plunged Into Raging Floodwaters
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Meet The Dire Wolf Trio Remus, Romulus And Khaleesi: How A Texas Lab Revived An Extinct Species
-
Massive New Jersey Wildfire Devastates 8,500 Acres, Threatens Wildlife and Communities Amid Historic Drought
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
